As of 2025-06-29, the EV/EBITDA ratio of Seneca Biopharma Inc (SNCA) is -1.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SNCA's latest enterprise value is 18.18 mil USD. SNCA's TTM EBITDA according to its financial statements is -16.20 mil USD. Dividing these 2 quantities gives us the above SNCA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |